ZLB BEHRING ANNOUNCES AVAILABILITY OF HUMATE-P WITH SMALLER DILUENT
ZLB Behring today announced that Humate-P (Antihemophilic Factor/von Willebrand
Factor Complex (Human), Dried, Pasteurized) is now available featuring a smaller
diluent — 50 percent less in all assay sizes. The new formulation, which
bears the current safety and efficacy profile of Humate-P, offers added convenience
to patients, healthcare professionals, and caregivers who administer Humate-P.
Humate-P is the only factor concentrate approved by the U.S. Food & Drug
Administration for use in treating adult and pediatric patients who experience
spontaneous and trauma-induced bleeding episodes in severe von Willebrand Disease
(VWD), and in mild or moderate VWD where the use of desmopressin is known or
suspected to be inadequate.